Skip to content
2000
Volume 15, Issue 4
  • ISSN: 2210-3031
  • E-ISSN: 2210-304X

Abstract

Recent years have witnessed an enormous spike in interest in cell-derived particles (CDPs) that are also called Extracellular vesicles (EVs) due to their potential uses in both treatments and diagnostics. Small vesicles or particles, including apoptotic bodies, microvesicles, and exosomes, are released from both healthy and sick cells. They carry bioactive substances from their parent cells and transfer this cargo to target cells making them potential candidates for therapeutic interventions and diagnostic applications. These phospholipid-enclosed nanovesicles have multiple benefits over other carriers of biological materials, including high biocompatibility, high circulation stability, core propensity to target cells, low immunogenicity, ability to shield payload from degradation and biological barrier-crossing properties that make them unique. Cell-derived particles are used for evaluating treatment efficacy in addition to treating diseases by tracking changes in the payload composition of extracellular vesicles over time as real-time monitoring, thus treatment plans can be improved and patient outcomes can be forecast. Moreover, extracellular vesicles have gained attention as possible biomarkers because of their capacity to hold and transport biomolecules, and many biomarkers which might provide important details about cellular functions and the onset of illness. Cell-derived particles reflect the condition of the parent cell, making them an excellent source of biomarkers for a variety of illnesses. They can reveal information about the existence and course of illnesses and serve as a noninvasive substitute for conventional tissue biopsies. This review highlights the potential of Extracellular vesicles (EVs) as drug delivery carriers and as novel non-invasive molecular diagnostic tools for the prognosis of fatal illnesses. This article reveals the fundamental characteristics of EVs, the types of EVs, characteristics of EVs as biomarkers. Further, challenges in the isolation and characterization of extracellular vesicles, and applications of extracellular vesicles in drug delivery, are also succinctly summarized in this review article.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ddl/10.2174/0122103031368788250708153633
2025-07-14
2025-12-23

  • From This Site

    /content/journals/ddl/10.2174/0122103031368788250708153633
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CiferriM.C. QuartoR. TassoR. Extracellular vesicles as biomarkers and therapeutic tools: From pre-clinical to clinical applications.Biology202110535910.3390/biology1005035933922446
     [Google Scholar]
  2. ChungI.M. RajakumarG. VenkidasamyB. SubramanianU. ThiruvengadamM. Exosomes: Current use and future applications.Clin. Chim. Acta202050022623210.1016/j.cca.2019.10.02231678573
     [Google Scholar]
  3. PalazzoloS. CanzonieriV. RizzolioF. The history of small extracellular vesicles and their implication in cancer drug resistance.Front. Oncol.20221294884310.3389/fonc.2022.94884336091133
     [Google Scholar]
  4. HanQ.F. LiW.J. HuK.S. GaoJ. ZhaiW.L. YangJ.H. ZhangS.J. Exosome biogenesis: Machinery, regulation, and therapeutic implications in cancer.Mol. Cancer202221120710.1186/s12943‑022‑01671‑036320056
     [Google Scholar]
  5. StåhlA. JohanssonK. MossbergM. KahnR. KarpmanD. Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases.Pediatr. Nephrol.2019341113010.1007/s00467‑017‑3816‑z29181712
     [Google Scholar]
  6. ZhaoY. LiX. ZhangW. YuL. WangY. DengZ. LiuM. MoS. WangR. ZhaoJ. LiuS. HaoY. WangX. JiT. ZhangL. WangC. Trends in the biological functions and medical applications of extracellular vesicles and analogues.Acta Pharm. Sin. B20211182114213510.1016/j.apsb.2021.03.01234522580
     [Google Scholar]
  7. LiuW. BaiX. ZhangA. HuangJ. XuS. ZhangJ. Role of exosomes in central nervous system diseases.Front. Mol. Neurosci.20191224010.3389/fnmol.2019.0024031636538
     [Google Scholar]
  8. SoltészB. BuglyóG. NémethN. SzilágyiM. PösO. SzemesT. BaloghI. NagyB. The role of exosomes in cancer progression.Int. J. Mol. Sci.2021231810.3390/ijms2301000835008434
     [Google Scholar]
  9. HeA. WangM. LiX. ChenH. LimK. LuL. ZhangC. Role of exosomes in the pathogenesis and theranostic of Alzheimer’s disease and Parkinson’s disease.Int. J. Mol. Sci.202324131105410.3390/ijms24131105437446231
     [Google Scholar]
  10. HowittJ. HillA.F. Exosomes in the pathology of neurodegenerative diseases.J. Biol. Chem.201629152265892659710.1074/jbc.R116.75795527852825
     [Google Scholar]
  11. JadliA.S. ParasorA. GomesK.P. ShandilyaR. PatelV.B. Exosomes in cardiovascular diseases: Pathological potential of nano-messenger.Front. Cardiovasc. Med.2021876748810.3389/fcvm.2021.76748834869682
     [Google Scholar]
  12. KalluriR. LeBleuV.S. The biology, function, and biomedical applications of exosomes.Science20203676478eaau697710.1126/science.aau697732029601
     [Google Scholar]
  13. ClancyJ.W. SchmidtmannM. D’Souza-SchoreyC. The ins and outs of microvesicles.FASEB Bioadv.20213639940610.1096/fba.2020‑0012734124595
     [Google Scholar]
  14. ZhouB. XuK. ZhengX. ChenT. WangJ. SongY. ShaoY. ZhengS. Application of exosomes as liquid biopsy in clinical diagnosis.Signal Transduct. Target. Ther.20205114410.1038/s41392‑020‑00258‑932747657
     [Google Scholar]
  15. NawazM. ShahN. ZanettiB.R. MaugeriM. SilvestreR.N. FatimaF. NederL. ValadiH. Extracellular vesicles and matrix remodeling enzymes: The emerging roles in extracellular matrix remodeling, progression of diseases and tissue repair.Cells201871016710.3390/cells710016730322133
     [Google Scholar]
  16. PanagiotouN. Wayne DaviesR. SelmanC. ShielsP.G. Microvesicles as vehicles for tissue regeneration: Changing of the guards.Curr. Pathobiol. Rep.20164418118710.1007/s40139‑016‑0115‑527882267
     [Google Scholar]
  17. BuzasE.I. The roles of extracellular vesicles in the immune system.Nat. Rev. Immunol.202323423625010.1038/s41577‑022‑00763‑835927511
     [Google Scholar]
  18. Atkin-SmithG.K. TixeiraR. PaoneS. MathivananS. CollinsC. LiemM. GoodallK.J. RavichandranK.S. HulettM.D. PoonI.K.H. A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure.Nat. Commun.201561743910.1038/ncomms843926074490
     [Google Scholar]
  19. YuL. ZhuG. ZhangZ. YuY. ZengL. XuZ. WengJ. XiaJ. LiJ. PathakJ.L. Apoptotic bodies: Bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials.J. Nanobiotechnology202321121810.1186/s12951‑023‑01969‑137434199
     [Google Scholar]
  20. BattistelliM FalcieriE. Apoptotic bodies: Particular extracellular vesicles involved in intercellular communication.Advances in Medical Biochemistry, Genomics, Physiology, and Pathology1st edJenny Stanford Publishing202147348610.1201/9781003180449‑20
     [Google Scholar]
  21. SurmanM. Kędracka-KrokS. JankowskaU. DrożdżA. StępieńE. PrzybyłoM. Proteomic profiling of ectosomes derived from paired urothelial bladder cancer and normal cells reveals the presence of biologically-relevant molecules.Int. J. Mol. Sci.20212213681610.3390/ijms2213681634202855
     [Google Scholar]
  22. YuanaY. SturkA. NieuwlandR. Extracellular vesicles in physiological and pathological conditions.Blood Rev.2013271313910.1016/j.blre.2012.12.00223261067
     [Google Scholar]
  23. KoniuszS. AndrzejewskaA. MuracaM. SrivastavaA.K. JanowskiM. LukomskaB. Extracellular vesicles in physiology, pathology, and therapy of the immune and central nervous system, with focus on extracellular vesicles derived from mesenchymal stem cells as therapeutic tools.Front. Cell. Neurosci.20161010910.3389/fncel.2016.0010927199663
     [Google Scholar]
  24. MeehanB. RakJ. Di VizioD. Oncosomes – large and small: What are they, where they came from?J. Extracell. Vesicles2016513310910.3402/jev.v5.3310927680302
     [Google Scholar]
  25. MalliaA. GianazzaE. ZoanniB. BrioschiM. BarbieriS.S. BanfiC. Proteomics of extracellular vesicles: Update on their composition, biological roles and potential use as diagnostic tools in atherosclerotic cardiovascular diseases.Diagnostics2020101084310.3390/diagnostics1010084333086718
     [Google Scholar]
  26. LiuJ. ChenY. PeiF. ZengC. YaoY. LiaoW. ZhaoZ. Extracellular vesicles in liquid biopsies: Potential for disease diagnosis.BioMed Res. Int.202120211661124410.1155/2021/661124433506022
     [Google Scholar]
  27. GriffithsH. MøllerL. BartoszG. BastA. Bertoni-FreddariC. CollinsA. CookeM. CoolenS. HaenenG. HobergA.M. LoftS. LunecJ. OlinskiR. ParryJ. PompellaA. PoulsenH. VerhagenH. AstleyS.B. Biomarkers.Mol. Aspects Med.2002231-310120810.1016/S0098‑2997(02)00017‑112079771
     [Google Scholar]
  28. ZhangX. YuanX. ShiH. WuL. QianH. XuW. Exosomes in cancer: Small particle, big player.J. Hematol. Oncol.2015818310.1186/s13045‑015‑0181‑x26156517
     [Google Scholar]
  29. ZhengH. ZhanY. LiuS. LuJ. LuoJ. FengJ. FanS. The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications.J. Exp. Clin. Cancer Res.201837122610.1186/s13046‑018‑0901‑530217217
     [Google Scholar]
  30. BarniePA AfrifaJ GyamerahEO AmoaniB Extracellular vesicles as biomarkers and therapeutic targets in cancers.PhysiologyIntechOpen202210.5772/intechopen.101783
     [Google Scholar]
  31. LiuS. LiaoY. HosseinifardH. ImaniS. WenQ. Diagnostic role of extracellular vesicles in cancer: A comprehensive systematic review and meta-analysis.Front. Cell Dev. Biol.2021970579110.3389/fcell.2021.70579134722499
     [Google Scholar]
  32. BeatrizM. VilaçaR. LopesC. Exosomes: innocent bystanders or critical culprits in neurodegenerative diseases.Front. Cell Dev. Biol.2021963510410.3389/fcell.2021.63510434055771
     [Google Scholar]
  33. VandendriesscheC. BalusuS. Van CauwenbergheC. BrkicM. PauwelsM. PlehiersN. BruggemanA. DujardinP. Van ImschootG. Van WonterghemE. HendrixA. BaekeF. De RyckeR. GevaertK. VandenbrouckeR.E. Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease.Acta Neuropathol. Commun.20219114310.1186/s40478‑021‑01245‑z34425919
     [Google Scholar]
  34. BehrensF. HolleJ. KueblerW.M. SimmonsS. Extracellular vesicles as regulators of kidney function and disease.Intensive Care Med. Exp.20208S1Suppl. 12210.1186/s40635‑020‑00306‑233336297
     [Google Scholar]
  35. ErdbrüggerU. LeT.H. Extracellular vesicles in renal diseases: More than novel biomarkers?J. Am. Soc. Nephrol.2016271122610.1681/ASN.201501007426251351
     [Google Scholar]
  36. Garcia-ContrerasM. BrooksR.W. BoccuzziL. RobbinsP.D. RicordiC. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus.Eur. Rev. Med. Pharmacol. Sci.201721122940295628682421
     [Google Scholar]
  37. PangH. LuoS. XiaoY. XiaY. LiX. HuangG. XieZ. ZhouZ. Emerging roles of exosomes in T1DM.Front. Immunol.20201159334810.3389/fimmu.2020.59334833324409
     [Google Scholar]
  38. Perez-HernandezJ CortesR Extracellular vesicles as biomarkers of systemic lupus erythematosus.Dis. Markers.2015201561353610.1155/2015/613536
     [Google Scholar]
  39. EstesS. KonstantinovK. YoungJ.D. Manufactured extracellular vesicles as human therapeutics: Challenges, advances, and opportunities.Curr. Opin. Biotechnol.20227710277610.1016/j.copbio.2022.10277636041354
     [Google Scholar]
  40. MurphyD.E. de JongO.G. BrouwerM. WoodM.J. LavieuG. SchiffelersR.M. VaderP. Extracellular vesicle-based therapeutics: Natural versus engineered targeting and trafficking.Exp. Mol. Med.20195133210.1038/s12276‑019‑0223‑530872574
     [Google Scholar]
  41. PiffouxM. VolatronJ. SilvaA. GazeauF. Thinking quantitatively of RNA-based information transfer via extracellular vesicles: Lessons to learn for the design of RNA-loaded evs.Pharmaceutics20211311193110.3390/pharmaceutics1311193134834346
     [Google Scholar]
  42. WahlgrenJ. KarlsonT.D.L. BrisslertM. Vaziri SaniF. TelemoE. SunnerhagenP. ValadiH. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.Nucleic Acids Res.2012401713010.1093/nar/gks46322618874
     [Google Scholar]
  43. MengW. HeC. HaoY. WangL. LiL. ZhuG. Prospects and challenges of extracellular vesicle-based drug delivery system: Considering cell source.Drug Deliv.202027158559810.1080/10717544.2020.174875832264719
     [Google Scholar]
  44. GangadaranP. LiX.J. LeeH.W. OhJ.M. KalimuthuS. RajendranR.L. SonS.H. BaekS.H. SinghT.D. ZhuL. JeongS.Y. LeeS.W. LeeJ. AhnB.C. A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice.Oncotarget201786610989410991410.18632/oncotarget.2249329299117
     [Google Scholar]
  45. MalhotraH. SheokandN. KumarS. ChauhanA.S. KumarM. JakharP. BoradiaV.M. RajeC.I. RajeM. Exosomes: Tunable nano vehicles for macromolecular delivery of transferrin and lactoferrin to the specific intracellular compartment.J. Biomed. Nanotechnol.20161251101111410.1166/jbn.2016.222927305829
     [Google Scholar]
  46. AkbarA. MalekianF. BaghbanN. KodamS.P. UllahM. Methodologies to isolate and purify clinical grade extracellular vesicles for medical applications.Cells202211218610.3390/cells1102018635053301
     [Google Scholar]
  47. SalmondN. WilliamsK.C. Isolation and characterization of extracellular vesicles for clinical applications in cancer – Time for standardization?Nanoscale Adv.2021371830185210.1039/D0NA00676A36133088
     [Google Scholar]
  48. BanoR. AhmadF. MohsinM. A perspective on the isolation and characterization of extracellular vesicles from different biofluids.RSC Advances20211132195981961510.1039/D1RA01576A35479207
     [Google Scholar]
/content/journals/ddl/10.2174/0122103031368788250708153633
Loading
Extracellular Vesicles: Innovative Nanotheranostic Platforms for Precision Drug Delivery
Drug Deliv Lett 15, 465 (2025); https://doi.org/10.2174/0122103031368788250708153633
/content/journals/ddl/10.2174/0122103031368788250708153633
/content/journals/ddl/10.2174/0122103031368788250708153633
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): apoptotic bodies; biomarker; exosomes; Extracellular vesicles; liquid biopsy; mesenchymal stem cell (MSCs); microvesicles; nanocarrier; oncosomes

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test